6Dharnidhatka VR,Stablein DM,Hramon WE. Post-transpant infections now exceed acute rejection as cause for hospitalization:a report of the NAPRTCS[J].American Journal of Transplantation,2004,(03):384-389.
7Patlolla V,Zhong X,Reed GW. Efficacy of AntiIL-2 Receptor Antibodies Compared to no Induction and to Antilymphocyte Antibodies in Renal Transplantation[J].American Journal of Transplantation,2007,(07):1832-1842.doi:10.1375/twin.11.5.531.
8Ciancio G,Mattiazzi A,Roth D. The use of daclizumab as induction therapy in combination with tacrolimus and mycophenolate mofetil in recipients with previous transplants[J].Clinical Transplantation,2003,(05):428-432.doi:10.1142/S0218301311019283.
9Sommer BG,Henry ML,Ferguson RM. Sequential antilymphoblast globulin and cyclosporine for renal transplantation[J].Transplantation,1987,(01):85-90.doi:10.1097/00007890-198701000-00019.
10Kirk AD,Mannon RB,Swanson S J. Strategies for minimizing immunosuppression in kidney Transplantation[J].Transplant International,2005,(01):2-14.doi:10.1111/j.1432-2277.2004.00019.x.
